Skip to main content

Table 2 Distribution of FCN3 genotypes (rs4494157 and rs10794501) in controls and patients with RF

From: The clinical value of ficolin-3 gene polymorphism in rheumatic heart disease. An Egyptian adolescents study

 

Control n (%)

RF without RHD n (%)

RF with RHD n (%)

OR (95% CI)

P

rs4494157

Genotype distribution

 CC

64 (80)

49 (61.25)

43 (53.75)

  

 CA

10 (12.5)

20 (25)

23 (28.75)

2.61 (1.12–6.08)a

3.42 (1.48 -7.91) b

0.026a*

0.005b*

 AA

6 (7.5)

11 (13.75)

14 (17.5)

3.47 (1.24–9.74) b

0.026b*

 CA/AA

16 (20)

31 (38.75)

37 (46.25)

2.53 (1.24–5.14) a

3.44 (1.70–6.95) b

0.016 a *

0.0007 b *

Allele frequencies

 C

138 (86.25)

118 (73.75)

109 (68.12)

  

 A

22 (13.75)

42 (26.25)

51 (31.88)

2.23 (1.26–3.95)a

2.93 (1.68–5.14) b

0.008a*

0.0002b*

rs10794501

Genotype distribution

 TT

58 (72.5)

51 (63.75)

54 (67.5)

 

n.s

 TA

17 (21.25)

21 (26.25)

16 (20)

 AA

5 (6.25)

8 (10)

10 (12.5)

 TA/AA

22 (27.5)

29 (36.25)

26 (32.5)

Allele frequencies

 T

133 (83.1)

123 (76.9)

124 (77.5)

 

n.s

  A

27 (16.9)

37 (23.1)

36 (22.5)

  1. OR, odds ratio; CI, confidence intervals; RF, rheumatic fever; RHD, rheumatic heart disease; aRF patients without RHD vs. control; bRF patients with RHD vs. control; *Statistically significant different at P < 0.05 using Fisher exact test, n.s., non-significance